Established in 2016 by forensic scientist Dr Xanthé Mallett, FHID (short for Forensic Human Identification) is a specialist forensic human identification business created to provide investigators with forensically relevant information to help them help identify offenders or long-term unidentified John and Jane Does more quickly and with less wasted resources.

FHID is the Australian affiliate of Parabon NanoLabs, which developed and operates the Parabon Snapshot™ DNA Phenotyping Service. Snapshot is a revolutionary new DNA analysis technique that has the ability to produce the descriptive profile of the source of any human DNA sample, accurately predicting the physical appearance and ancestry of the donor.

Other services offered by FHID include the forensic analysis of images, and evaluation of skeletal remains for the purpose of establishing identity. Xanthé also acts as expert contributor to television series and documentaries. For services, please refer to “Forensic Services”.

FHID’s Foundation

Established in 2016, was initially established to make the Parabon Snapshot phenotyping service for investigators in Australia. DNA profiles are produced in Australia, by AGRF, a laboratory with service points across Australia that performs the DNA extraction and (if required) repair, before the DNA sequence is electronically sent to Parabon NanoLabs for phenotypic analysis, and creation of a Parabon Snapshot report.

Dr. Xanthé Mallett

Dr Xanthé Mallett, Director and CEO, established FHID Pty Ltd in 2016, as a result of her aim of improving methods of forensic human identification. Xanthé is a forensic anthropologist, and her PhD (University of Sheffield, 2008) focussed on augmenting facial recognition technologies. She has over 10 years experience undertaking forensic analyses, in the UK and Australia.

Parabon NanoLabs

Parabon NanoLabs, Inc. is a vertically integrated DNA technology company that develops next-generation therapeutic and forensic products, which leverage the enormous power of DNA. Staffed by a uniquely qualified team of scientists and technologists, with expertise ranging from bioinformatics and oncology to chemistry and computer science, the Company is bringing to market revolutionary new products and services made possible by recent advances in DNA sequencing, processing and manufacturing technologies.
Organized in the State of Delaware, Parabon NanoLabs is a for-profit, C-Corporation with headquarters in Reston, Virginia.

The Company is a small business as defined by the US Government’s Small Business Administration and is the recipient of numerous Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grants and contracts.
Established in 2008, as an on-going collaboration between Dr. Michael Norton, a pioneer in the field of DNA-based nanotechnology, and Dr. Steven Armentrout, serving as CEO of Parabon Computation (PCI). Parabon NanoLabs recently moved into the field of forensic investigation, through the developing trait prediction capabilities for forensics applications.


Is a not-for-profit organisation that, through a national network, provides genomic services and expertise that are easily accessible throughout Australia. AGRF seeks to empower Australia to be recognised for world-class genomics and innovation.
By exchanging and collaborating in knowledge expertise, providing local access to innovative and state-of-the-art genomic technologies, AGRF enable Australian academia and industry to advance leading edge genomic research internationally.
AGRF has a number of services accredited by the National Association of Testing Authorities, Australia (NATA)  in the field of Biological Testing and operates in compliance with the international standard ISO/IEC 17025:2005.

AGRF Australian Genome Research Facility